[Efficacy and safety of BTK inhibitor, venetoclax and rituximab in the treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma].

R Jiang, L M J Dai,Y Q Sha,Y Xia, Y Miao,S C Qin,W Wu,J Y Qiu, H L Bi,L Wang, L Fan,W Xu, J Y Li,H Y Zhu

Chinese Journal of Hematology(2023)

引用 0|浏览26
暂无评分
关键词
chronic lymphocytic leukemia/small,leukemia/small lymphocytic lymphoma,btk inhibitor,venetoclax
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要